Clinical trial
Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot
NCT04713657 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 16, 2022
- Completion date
- December 31, 2030
- Enrollment
- 40 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.